Article Information
vol. 2 no. 11
- Received January 8, 2017
- Accepted April 17, 2017
- .
Author Information
- Christina Guzzo1,*,
- David Ichikawa1,*,
- Chung Park2,
- Damilola Phillips1,
- Qingbo Liu1,
- Peng Zhang1,
- Alice Kwon1,
- Huiyi Miao1,
- Jacky Lu1,
- Catherine Rehm3,
- James Arthos4,
- Claudia Cicala4,
- Myron S. Cohen5,
- Anthony S. Fauci4,
- John H. Kehrl2 and
- Paolo Lusso1,†
- 1Viral Pathogenesis Section, Laboratory of Immunoregulation (LIR), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
- 2B-Cell Molecular Immunology Section, LIR, NIAID, NIH, Bethesda, MD 20892, USA.
- 3Clinical Research Section, LIR, NIAID, NIH, Bethesda, MD 20892, USA.
- 4Immunopathogenesis Section, LIR, NIAID, NIH, Bethesda, MD 20892, USA.
- 5Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
- ↵†Corresponding author. Email: plusso{at}niaid.nih.gov
↵* These authors contributed equally to this work.